ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
36.26
0.00%
US Tech 100
19,885.20
0.20%
S&P 500
5,631.22
0.28%
US Dollar vs CAD
1.36776
-0.01%
Bitcoin
63,547.25
-2.01%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Summit Therapeutics Inc (SMMT)

  7. Summit Therapeutics Inc (SMMT) News

SMMT

Summit Therapeutics (SMMT)

Summit Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SMMT
DateTimeSourceHeadlineSymbolCompany
03/27/20176:00AMGlobeNewswire Inc.Summit Therapeutics Provides Notice of Financial Results for the Fourth Quarter and Fiscal Year Ended 31 January 2017NASDAQ:SMMTSummit Therapeutics Inc
03/27/20176:00AMGlobeNewswire Inc.Summit to Extend Ongoing PhaseOut DMD Clinical Trial of Ezutromid in Patients With DMDNASDAQ:SMMTSummit Therapeutics Inc
03/15/20176:00AMGlobeNewswire Inc.Summit Therapeutics to Present at the Oppenheimer 27th Annual Healthcare ConferenceNASDAQ:SMMTSummit Therapeutics Inc
02/28/20176:00AMGlobeNewswire Inc.Summit Therapeutics Recognises 10th Annual Rare Disease DayNASDAQ:SMMTSummit Therapeutics Inc
02/14/20172:01PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SMMTSummit Therapeutics Inc
02/02/20176:00AMGlobeNewswire Inc.Summit Therapeutics to Participate in February Investor ConferencesNASDAQ:SMMTSummit Therapeutics Inc
02/01/20173:05PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
02/01/20176:00AMGlobeNewswire Inc.Summit Outlines Phase 3 Programme for Novel CDI Antibiotic Ridinilazole Following FDA and EMA Regulatory MeetingsNASDAQ:SMMTSummit Therapeutics Inc
01/18/20173:15PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
01/18/20176:00AMGlobeNewswire Inc.Summit Appoints Dr David Roblin as Chief Operating Officer and President of Research & DevelopmentNASDAQ:SMMTSummit Therapeutics Inc
12/15/20163:23PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
12/15/20166:00AMGlobeNewswire Inc.Summit Therapeutics Reports Financial Results for the Third Quarter Ended 31 October 2016 and Operational ProgressNASDAQ:SMMTSummit Therapeutics Inc
12/13/20169:00AMGlobeNewswire Inc.Summit Therapeutics to Report Financial Results for the Third Quarter Ended 31 October 2016 on 15 December 2016NASDAQ:SMMTSummit Therapeutics Inc
11/21/20169:11AMEdgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:SMMTSummit Therapeutics Inc
11/16/20166:00AMGlobeNewswire Inc.Summit Enrols Patients in the United States Into PhaseOut DMD, a Phase 2 Clinical Trial of Ezutromid in Patients With DMDNASDAQ:SMMTSummit Therapeutics Inc
10/06/20166:00AMGlobeNewswire Inc.Summit Therapeutics Presents Preclinical DMD Data at the 21st International Congress of the World Muscle SocietyNASDAQ:SMMTSummit Therapeutics Inc
10/04/20166:05AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
10/04/20166:01AMGlobeNewswire Inc.Summit to Host Conference Call to Discuss Exclusive License and Collaboration Agreement With Sarepta Therapeutics for Europea...NASDAQ:SMMTSummit Therapeutics Inc
10/04/20166:00AMGlobeNewswire Inc.Sarepta Therapeutics and Summit Enter Into Exclusive License and Collaboration Agreement for European Rights to Summit’s Ut...NASDAQ:SMMTSummit Therapeutics Inc
09/28/20167:11AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
09/27/20166:00AMGlobeNewswire Inc.Summit Receives Rare Pediatric Disease Designation From US FDA for Ezutromid in Treatment of Duchenne Muscular DystrophyNASDAQ:SMMTSummit Therapeutics Inc
09/26/20163:58PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
09/26/20166:00AMGlobeNewswire Inc.Summit Receives Fast Track Designation From US FDA for Ezutromid in the Treatment of Duchenne Muscular DystrophyNASDAQ:SMMTSummit Therapeutics Inc
09/12/20166:00AMGlobeNewswire Inc.Summit Launches Online Resource on Utrophin Modulation for the Duchenne Muscular Dystrophy CommunityNASDAQ:SMMTSummit Therapeutics Inc
09/08/20164:07PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
09/08/20166:00AMGlobeNewswire Inc.Summit Therapeutics Reports Financial Results for the Second Quarter Ended 31 July 2016 and Operational ProgressNASDAQ:SMMTSummit Therapeutics Inc
09/07/20166:00AMGlobeNewswire Inc.Summit Therapeutics to Present at 18th Annual Rodman & Renshaw Global Investment ConferenceNASDAQ:SMMTSummit Therapeutics Inc
09/05/20166:00AMGlobeNewswire Inc.Summit Therapeutics to Report Financial Results for the Second Quarter Ended 31 July 2016 on 8 September 2016NASDAQ:SMMTSummit Therapeutics Inc
08/09/20163:15PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
08/09/20166:00AMGlobeNewswire Inc.Summit Reports Positive Phase 1 New Formulation Data and Outlines Route to Market Strategy for DMD Candidate EzutromidNASDAQ:SMMTSummit Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:SMMT

Your Recent History

USOTC
AXXA
Exxe (PK)
USOTC
MGON
Megola (PK)
NASDAQ
FFIE
Faraday Future Intellige...
USOTC
IQST
iQSTEL (QX)
USOTC
IGPK
Intergrated Cannabis Sol... (PK)
USOTC
WDLF
Decentral Life (PK)
USOTC
RONN
Ronn Motor (PK)
USOTC
GRST
Ethema Health (PK)
USOTC
FNMA
Fannie Mae (QB)
USOTC
BLEG
Branded Legacy (PK)
USOTC
TPTW
TPT Global Tech (PK)
USOTC
ENZC
Enzolytics (PK)
USOTC
UBQU
Ubiquitech Software (PK)
USOTC
IFUS
Impact Fusion (PK)
USOTC
RNVA
Rennova Health (PK)
USOTC
DBMM
Digital Brand Media and ... (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved